ResearcherMayo ClinicNo recent work listed

Katarzyna A. Ellsworth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6269-4771; OpenAlex author ID A5024104572. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper

Papers 1

Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. Co-author DOI 10.1371/journal.pone.0070216 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liewei Wang · 1 shared paper, 2013 · strength 0.03
- Paper Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. DOI 10.1371/journal.pone.0070216 ↗
Brooke L. Fridley · 1 shared paper, 2013 · strength 0.03
- Paper Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. DOI 10.1371/journal.pone.0070216 ↗
Liang Li · 1 shared paper, 2013 · strength 0.03
- Paper Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. DOI 10.1371/journal.pone.0070216 ↗
Gloria M. Petersen · 1 shared paper, 2013 · strength 0.03
- Paper Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. DOI 10.1371/journal.pone.0070216 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.